Early research (Phase 1)Study completedNCT05418426
What this trial is testing
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
Who this might be right for
Vulvovaginal AtrophyVasomotor Symptoms
Daré Bioscience, Inc. 34